The Source Roundup: February 2024 Edition
Healthcare System Mergers and Investment Models for Enhanced Health Care Market Oversight – State Attorneys General, Health Departments, and Independent Oversight Entities (Milbank Memorial Fund) Erin C. Fuse Brown, Katherine L. Gudiksen The Source’s own Katherine L. Gudiksen co-authored this report for the Milbank Memorial Fund with Eric C. Fuse Brown, which assesses the tools state policy makers are using to address harmful health care market consolidation. Specifically, the report focuses on how states have broadened review authority by expanding the existing authority of the Attorney General (or other state agencies) and providing supplementary [...]
SB 2520
A bill to address pharmaceutical access, costs and transparency. Imposes new transparency requirements on pharmaceutical manufacturers and PBMs.
SB 2499
A bill to address pharmaceutical access, costs and transparency. Imposes new transparency requirements on pharmaceutical manufacturers and PBMs.
SB 2492
A bill to address pharmaceutical access, costs and transparency. Imposes new transparency requirements on pharmaceutical manufacturers and PBMs.